DXP Enterprises, Inc. (DXPE)

Nasdaq Industrials Trading Companies & Distributors S&P SmallCap 600
$140.68
+7.81 (+5.88%)
Close of Nov 06, 2026 · end-of-day data

DXPE 8-K filings in 2025

Every material Form 8-K DXP Enterprises filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2025616 on record in all
Latest filing in 2025Dec 22, 2025financing
High impact (4-5)0of 6 briefs
TonePositive4Neutral2
earnings 4financing 2
Dec 22, 4:30 PM ET

DXP Enterprises refinances term loan and adds $205 million in borrowings

Neutral financing Written later 1.012.038.01

DXP Enterprises closed a refinancing of its existing Senior Secured Term Loan B and raised an incremental $205 million, bringing total term loan borrowings to $848 million. The company says the transaction cuts its borrowing margin by 50 basis points and is expected to save an estimated $3.2 million in annual interest, with proceeds used to repay existing debt and for general corporate purposes and acquisitions. Shareholders should note the larger debt load, which is secured by substantially all of the company's assets.

  • Total Term Loan B borrowings of $848 million, including $643.0 million refinanced and a $205 million increase, maturing October 13, 2030
  • Priced at Term SOFR plus 3.25 percent; applicable margin reduced by 50 basis points
  • Company estimates $3.2 million in annual interest savings
  • Loan is secured by substantially all consolidated assets, with a secured leverage covenant of 5.75:1 to 4.75:1
Read the filing on SEC.gov ↗
Nov 6, 3:06 PM ET

DXP Enterprises Q3 sales rise 8.6% to $513.7 million; diluted EPS $1.31

Positive earnings Written later 2.02

DXP Enterprises reported third quarter 2025 results for the period ended September 30, 2025. Sales rose 8.6% year over year to $513.7 million, net income rose 2.5% to $21.6 million, and GAAP diluted EPS was $1.31, up from $1.27. The company also said it had completed three acquisitions through the third quarter and two more after quarter end.

  • Sales of $513.7 million, up 8.6% from $472.9 million in Q3 2024 and up 3.0% from $498.7 million in Q2 2025
  • GAAP diluted EPS of $1.31 vs. $1.27 in Q3 2024; adjusted diluted EPS of $1.34 vs. $1.43
  • Adjusted EBITDA of $56.5 million vs. $52.4 million; Supply Chain Services revenue fell 5.0% to $63.0 million
  • Total debt outstanding was $644.0 million and cash was $123.8 million as of September 30, 2025
Read the filing on SEC.gov ↗
Aug 7, 2:46 PM ET

DXP Enterprises Q2 sales rise 11.9% to $498.7 million; diluted EPS $1.43

Positive earnings Written later 2.02

DXP Enterprises reported second quarter 2025 results on August 6, 2025, with sales of $498.7 million, up 11.9% from a year earlier, and net income of $23.6 million, up 41.3%. Diluted earnings per share were $1.43, compared with $1.00 in the second quarter of 2024, and Adjusted EBITDA rose to $57.3 million. The filing gives no new full-year guidance, and the company said it expects at least three or four more acquisitions in the second half of 2025.

  • Sales of $498.7 million, up 11.9% from $445.6 million in Q2 2024 and up 4.6% from $476.6 million in Q1 2025
  • Diluted EPS of $1.43 versus $1.00 in Q2 2024; net income of $23.6 million versus $16.7 million
  • Adjusted EBITDA of $57.3 million, an 11.5% margin, versus $48.2 million (10.8% margin) in Q2 2024
  • Free cash flow of $8.3 million versus $5.9 million a year earlier; total debt outstanding was $626.8 million as of June 30, 2025
Read the filing on SEC.gov ↗
Jul 8, 6:08 PM ET

DXP Enterprises raises ABL revolver commitments by $50 million to $185 million

Neutral financing Written later 1.012.038.01

DXP Enterprises entered an Increase Agreement on July 1, 2025, raising commitments under its existing asset-based revolving credit facility from $135 million to $185 million. The company says the added capacity provides liquidity and flexibility for its acquisition strategy, and the other terms of the facility were not amended.

  • Commitments under the ABL Facility rose by $50 million, from $135 million to $185 million, under an Increase Agreement dated July 1, 2025.
  • Up to $175.0 million is available to US borrowers and up to $10.0 million to Canadian borrowers.
  • Other material terms of the ABL Facility remain in effect and were not otherwise amended, according to the filing.
  • Goldman Sachs Bank USA is listed as lender and Bank of America, N.A. as agent for the lenders.
Read the filing on SEC.gov ↗
May 8, 3:25 PM ET

DXP Enterprises Q1 sales rise 15.5% to $476.6 million; diluted EPS $1.25

Positive earnings Written later 2.02

DXP Enterprises reported first-quarter 2025 results, with sales up 15.5% year over year to $476.6 million and net income of $20.6 million, compared with $11.3 million a year earlier. Diluted EPS rose to $1.25 from $0.67, though free cash flow was negative $16.9 million, compared with positive $24.1 million in the first quarter of 2024.

  • Sales of $476.6 million vs. $412.6 million in Q1 2024; acquisitions added $31.1 million
  • Diluted EPS of $1.25 vs. $0.67; Adjusted EBITDA of $52.5 million vs. $40.3 million
  • Free cash flow of negative $16.9 million vs. positive $24.1 million; purchases of property and equipment were $19.9 million
  • Cash of $114.3 million and total debt of $647.3 million as of March 31, 2025
Read the filing on SEC.gov ↗
Mar 7, 5:13 PM ET

DXP Enterprises Q4 sales rise to $470.9 million; full-year diluted EPS $4.22

Positive earnings Written later 2.02

DXP Enterprises reported fourth-quarter and fiscal 2024 results in a press release furnished under Item 2.02. Fourth-quarter sales rose to $470.9 million from $407.0 million, and diluted EPS rose to $1.29 from $0.94. For the full year, sales grew 7.4 percent to $1.8 billion and net income reached $70.5 million, up from $68.8 million, so shareholders saw higher sales and profit on both measures.

  • Q4 2024 sales were $470.9 million versus $407.0 million in Q4 2023; diluted EPS was $1.29 versus $0.94.
  • Fiscal 2024 diluted EPS was $4.22 versus $3.89 in fiscal 2023; net income was $70.5 million versus $68.8 million.
  • Fiscal 2024 free cash flow was $77.1 million, down from $94.0 million in fiscal 2023.
  • The company refinanced its Senior Secured Term Loan B, raising $649.5 million, and repurchased 0.6 million shares for $28.8 million in fiscal 2024.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DXP Enterprises filing is on SEC EDGAR ↗. 8-K briefs of other companies →